Motegrity (prucalopride)

Manufacturer:
Takeda
Route of Administration: 
Oral
Site of Care:
Outpatient
Website: 
    Enrollment Forms:
    Synergen Prescription Form

    Approved Indication:

    treatment of chronic idiopathic constipation in adults

    Conditions:

    • Chronic Idiopathic Constipation (CIC)

    Therapeutic Area:

    • Gastroenterology